Hendrik van Dullemen - Research output - the University of Groningen research portal

102 Article
24 Meeting Abstract
3 Letter
2 Abstract
More

2 results

Filter

2016
In a Dutch real-life inflammatory bowel disease score cohort with 90% prior anti-tumour necrosis factor failure, vedolizumab showed a 25% remission rate: a retrospective multicentre study
Gabriëls, R. Y., de Graaf, A. P. J., Meijssen, M. A. C., Gotz, J., Mensink, P., Russel, M., van Dullemen, H., ter Steege, R. W. F., Weersma, R. & Dijkstra, G., 2016.
Research output: Contribution to conference › Abstract › Academic
The value of endoscopic ultrasonography in a PET/CT upfront model in staging esophageal cancer with respect to treatment decision
Hulshoff, J.-B., de Boer, H., Noordzij, W., Nagengast, W., van Dullemen, H., Mul, V. & Plukker, J. T. H. M., 2016.
Research output: Contribution to conference › Abstract › Academic